Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

By R. Jope, Christopher J. Yuskaitis, Eléonore Beurel. Neurochemical Research, 2007

816 citations recorded by the source corpus.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/f570e6076ba59302f91d8b3bf75d7039e4606cf0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Eléonore Beurel
2. S. Grieco
3. R. Jope

Citations in the corpus

• The GSK3 hypothesis of Alzheimer's disease (2008, background): “Insulin transiently increases tau phosphorylation in human neuroblastoma cells, but this is soon followed by a reduction in tau phosphorylation, which correlates with the activation and subsequent inhibition of GSK3 (Lesort et al. 1999).”
• Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases (2014, background): “Diseases involving inflammation in the periphery have also been shown to benefit from the anti-inflammatory effects of GSK3 inhibitors (Jope et al., 2007).”